AstraZeneca PLC June 2025 Report: Executive Charitable Share Donation Revealed

Here are the key insights extracted from the financial report:

1. Company Details:

• Name: AstraZeneca PLC
• Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
• SEC File Number: 001-11960
• Form Submitted: 6-K

2. Reporting Period:

• The report pertains to the month of June 2025.

3. Director Transactions:

• Person Reporting: Aradhana Sarin
• Position: Executive Director and Chief Financial Officer
• Transaction Date: June 10, 2025
• Nature of Transaction: Gift of 200 American Depositary Shares (ADSs) to charity for nil consideration.
• Details of Shares: Each ADS represents one half of an ordinary share of $0.25 each in the Company.

4. Regulatory Compliance:

• The transaction was reported in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law.

5. Transaction Summary:

• Description of Financial Instrument: AstraZeneca PLC American Depositary Shares
• Identification Code: CUSIP: 046353108
• Place of Transaction: Outside a trading venue
• Volume of Shares Transacted: 200
• Price of Shares: Not applicable as it was a gift transaction.

6. Additional Notes:

• The report was filed as an initial notification regarding the transaction.
• The document includes standard compliance declarations regarding annual reports under Form 20-F or Form 40-F.

This information provides a clear overview of recent insider transactions regarding AstraZeneca PLC, highlighting the charitable action taken by a senior executive, which may reflect positively on the company's corporate governance practices.